RxDoctor Payments Data

Hamad Ahmad, MD

Family Medicine · Millington, TNNPI 1013271485

Payments from drug & device makers

$1,537in general payments, 2019–2025

Across 71 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$581
  • GSK$225
  • AbbVie$161
  • Merz North America, Inc.$109
  • AstraZeneca$105
  • Exact Sciences$55
  • plus $302 from 11 others

What the payments were for

  • Food & beverage$1,537100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,537 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$307,529
Medicare patients
650
Services billed
19,244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$23,665
EliquisApixaban15$18,843
MounjaroTirzepatide17$18,180
FarxigaDapagliflozin Propanediol15$15,842
OzempicSemaglutide12$15,236
Albuterol Sulfate HfaAlbuterol Sulfate59$1,309
Atorvastatin Calcium64$654
Fluticasone Propionate72$648
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide23$485
Pantoprazole Sodium32$416
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav41$408
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst28$387
Methylprednisolone44$320
Gabapentin31$307
Losartan Potassium30$276

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$225$23,66528 claims
PfizerEliquis$29$18,84315 claims
Lilly USA, LLCMounjaro$46$18,18017 claims
AstraZenecaFarxiga$105$15,84215 claims
Novo NordiskOzempic$581$15,23612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Millington

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →